HeyJaredLeslie Cantu
- Indexed articles, last 90 days
- 1
- Latest publication
- Sep 14, 2026
- Outlet visibility, for Postandcourier
- Top 50K sites
- Earliest in this view
- Sep 14, 2026
Latest articles
MUSC: Promising new option for pancreatic cancer (opens the original)
Read excerpt
Thunderous applause at this year’s American Society for Clinical Oncology (ASCO) meeting in May — hardly the typical reaction at a medical conference — greeted the announcement of results of a phase III clinical trial for a new drug to treat metastatic pancreatic cancer. Doctors and patients alike have been anxious to get their hands on the drug, daraxonrasib. Throughout the summer, it was available only under the Expanded Access Program (EAP), which allows patients with life-threatening illness
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Postandcourier, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.